ACS	acute coronary syndrome
APACE	Advantageous Predictors of Acute Coronary Syndrome Evaluation
AUC	area under the receiver operating characteristic curve
CI	confidence interval
AMI	acute myocardial infarction
CKD	chronic kidney disease
CMR	cardiac magnetic resonance
cMyBP-C	cardiac myosin-binding protein C
cMyC	circulating cMyBP-C biomarker signal
cTnI	cardiac troponin I
cTnT	cardiac troponin T
CRP	C-reactive protein
ECG	electrocardiogram
ED	emergency department
eGFR	estimated glomerular filtration rate
ELISA	enzyme-linked immunosorbent assay
ESC	European Society of Cardiology
HF	heart failure
GRADE	Grading of Recommendations Assessment, Development and Evaluation
hs-cTn	cardiac troponin measured with a high-sensitivity assay
hs-cTnI	cardiac troponin I measured with a high-sensitivity assay
hs-cTnT	cardiac troponin T measured with a high-sensitivity assay
LoD	limit of detection
LoQ	limit of quantification
LV	left ventricular
MACE	major adverse cardiovascular events
MI	myocardial infarction
MVO	microvascular obstruction
MYBPC3	myosin-binding protein C3 gene
MYC/c-Myc	MYC proto-oncogene/protein c-Myc
NPV	negative predictive value
NR	not reported
NSTEMI	non-ST-segment elevation myocardial infarction
NT-proBNP	N-terminal pro-B-type natriuretic peptide
PCI	percutaneous coronary intervention
POCT	point-of-care testing
PPV	positive predictive value
STEMI	ST-segment elevation myocardial infarction
TAT	turnaround time